ELI LILLY & Co — Director's Dealing 2015

Feb 4, 2015

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: LILLY ELI & CO (LLY)
CIK: 0000059478
Period of Report: 2014-12-31

Reporting Person: Mahony Susan (SVP & Pres., Lilly Oncology)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-12-04	Common Stock	G	730	—	Disposed	86757	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1599	Indirect
Common Stock	1589	Indirect
Common Stock	8984	Indirect

Footnotes

F1: Reporting person disclaims beneficial ownership of these shares.